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percutaneous approach for revasculadzation and replacement of transvenous pacemaker 
system is feasible, and can be an altamative to surgery for patients presenting with SVC 
syndrome due to chronic pacemaker leads. 
1115-110 Cardiac Memory :  E f fects  on QT Interval and Dispersion 
Maher C. Nahlawi, Michael Waligora, Stewart M. Spies, Robert O. Bonow, Alan H. 
Kadish, Jeffrev J. Goldbaraer. Northwestern Universi~ Medical School, Chicago, Illinois. 
To evaluate the effects of Iong-tarm ventdcular pacing (LTVP) on the QT interval (QTI) 
and QT dispersion (QTD), 12 subjects (8 women), mean age 68 + 12 years, with dual 
chamber pacemakers, normal left ventdcular function, and intact AV conduction were 
studied. Patients had standard 12 lead ECGs after 1 week of atdal pacing only (Base), 
after I week of AV pacing with an AV delay of 100 ms to ensure 100% ventdcolar pacing 
(LTVP), immediately after cessation of LTVP, and 2, 5, 8, 24, and 32 hours after cessa- 
tion of LTVP. All data were acquired at a pacing rate of 80 bpm. QTI was measured in 
each lead, and the longest interpretable QTI was reported for each individual ECG. QTD 
was defined as the maximum QTI minus the minimum QTL 
Results: Persistent T wave inversions characteristic of cardiac memory were evident on 
all ECGs after cessation of LTVP (0-32 hours). The figure shows QTI and QTD. QTI and 
QTD were significantly prolonged during LTVP and after cessation of LTVP (p<O.04 ver- 
sus Base) for up to 5-8 hours and gradually returned to baseline values. 
Conclusion: After cessation of LTVP, the QTI and QTD are prolonged. These changes 
resolve before the T wave inversions characteristic of cardiac memory, suggesting that 
LTVP has multiple electrophysiologic effects on ventdcular repelarization with different 
time courses of recovery. 
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1116-103 Dif ferent ial  Catecho lamine  Response  in Di f ferent Types 
of Neurocardiogenic Syncope 
Staffan Loscher. Frank Mickley, Martin Ludewig, Andreas Harfmann, DepL of Cardiology, 
SL Georg Hospital, Leipzig, Germany. 
Background: Syncopal episodes are frequently caused by a neurohumoral mechanism. 
Tilt-table('l-r) - testing has been established as a diagnostic tool to detect and differenti- 
ate neuro-cardiogenic syncope. Few data exist about the neurohumoral profile during TT- 
testing. It was the goal of this study to determine catecholamine profiles during TT- test- 
ing induced syncope. 
Method: 60 patients ( 26 male, 34 female, mean age 60,4 ± 18,7 years) with a history of 
syncopal episodes of undetermined origin underwent a l-r- testing protocol (70 ° tilt, 45 
minutes). Syncope was inducible in 33,3 % of all patients. Episodes were classified as 
vasodepressant syncope (VS) or cardioinhibitory syncope(CS). 
22 Patients (mean age 58,9 ± 17,6 years) without a history of syncopel episodes served 
as controls. 
Results: Catecholamine levels were determined at the begin of the test and at the time 
of syncope or at the end of the test if no syncope occurred. Catecholamioe response is 
depicted in table I 
Adrenaline Noradranaline (ng/I) Dopamine 
(ng/I) (ng/I) 
VS- type(n = 10) 
Testbegin 47,7 + 20 116,3 ± 84 18,1 +_ 8 
Syncope 82,1 ± 59 154,1 ± 107 32,1 ± 20 
CS -type (n= 10) 
Testbegin 107,2 ± 68 ** 348,1 ± 161 ** 47,0 ± 32** 
Syncope 258,6 + 159++** 415,8 ± 188 54,6 ± 35 
Non-inducible (n = 40) 
Testbegin 49,3 ± 28 171,2 ± 71 31,5 ± 24 
During Test 66,2 ± 41 197,8 ± 51 48,1 + 36 
Control ( n=22 ) 
Testbegin 34,7 ± 14 141,0 ± 49 21,7 ± 11 
During Test 49,9 +_ 18 180,3 ± 64 28,7 ± 14 
(++ p<0,0O5 test begin versus syncope, ** p<0,005 CS-type versus VS-type, syncope 
non-inducible and control group) 
Conctuelon: In conclusion, a different catecholamine response was found in CS-type 
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patients as compared to VS-type patients suggesting a different degree of sympathetic 
stimulation and a different pathophysiological mechanism. This finding may have implica- 
tions in patient selection for beta-blocker therapy of neurocardiogenic syncope. 
1116-104 Heart Rate Turbu lence Can Be Detected Af ter  Atr ia l  
P remature  Beat  
Idna Savelieva, Dan Wichtarle, Azad Ghuran, Maggie Meera, John Carom, Marek Malik, 
St George's Hospital Medical School, London, United Kingdom. 
Heart rate turbulence (HRT) describes a bi-phasic chronotropic response of sinus rhythm 
to a ventdcular premature beat (VPB). The aim of the study was to investigate whether 
an atrial premature beat (APB) can produce HRT and whether it can be described using 
ventdcular HRT quantifiers (turbulence onset, TO, and turbulence slope, TS). Methods: 
Thirty-saven subjects (54±16 years) referred for electrophysiologic evaluation for ventdc- 
ular tachyarrhythmias underwent a stimulation protocol consisting of 3 series of singte 
atrial and ventdcular extrastimuli delivered from the high right atrium and right venthcular 
apex prior to programmed etectdcal stimulation. Atrial and ventricular TO and TS (ATO, 
ATS, VTO, VTS) were calculated separately using a dedicated computer algorithm. 
Results: Expressed as mean±SD, VTO -2.03±0.42%, ATO 1.37±0.35% (p <0.001); VTS 
8.32±1.9 ms/RR, ATS 3.95±0.99 ms/RR (p <0.008). There was a strong correlation 
between VTS and ATS (r=0.71, p=0.0002; Figure, right) but not between VTO and ATO 
(r=0.83, p--0,074; left). Conclusions: HRT phenomenon is present after an APB, suggest- 
ing that similar baroreceptor mechanisms operate following both VPB and APB. After an 
APB, the late phase response (rhythm deceleration) is significantly attenuated and the 
early phase response is different than that after a VPB, indicating the presence of alter- 
native mechanisms. Atrial HRT can be measured using existing technique but algorithm 
adjustments are desirable. 
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1116-105 Character is t ics  of  Heart Rate Recovery  Af ter  Maximal  
Exercise 
Jeffrev J. Goldberoer. Prince J. Kannankedl, Francis K. Le, Alan H. Kadish, Northwestern 
University Medical School, Chicago, Illinois. 
Ten normal subjects (5 men, age 33±5 years) underwent maximal exercise (Ex) testing 
on a bicycle ergomster. On day 1, subjects exercised to maximum tolerated workload 
(140±29 Watts, 175±16 bpm) using a graded protocol with 5 minutes at peak workload. 
On day 2, subjects performed the identical Ex protocol as on day 1; one minute into the 
maximum Ex stage, atropine (0.04 mg/kg) was administered. Heart rate (HR) was 
recorded each minute dudng recovery for 10 minutes. Each subject's HR recovery data 
was fit to a monoexponential decay of the form HR = a+b * exp (-t/'~), where t is time in 
recovery, ~ is the time constant for HR recovery, and a and b are constants. Results: All 
subjects demonstrated a monoexponential decay in HR during recovery on each day (r 2 
0.94-1.0 [mean 0.98±0.02] on day 1 and 0.95-0.99 [mean 0.99¢0.01] on day 2). ~ was 
1.4±0.4 rain on day 1 and 1.6±0.5 min on day 2 (p=NS). HR recovery (HR at peak Ex 
minus HR 1 minute into recovery) was 42±9 bpm on day 1 and 22±8 bpm on day 2 
(p<0.0003). The table shows HR on each day at 0, 1, 5, and 10 minutes of recovery. 
There was a negative correlation between HR recovery at 1 minute and "~ (day 1: r2=0.51, 
p<0.02; day 2: r2=0.46, p<0.03). Conclusion: In normal subjects, approximately half the 
HR recovery is attributable to reactivation of parasympathetic effects. The time constant 
for HR recovery is inversely correlated with 1 minute HR recovery. As ~: provides a more 
complete charactadzation of HR recovery, this parameter may provide even better prog- 
nostic information than 1 minute HR recovery. 
HR at various time points in recovery (in bpm) 
0 min 1 min 5 min 10 min 
Day 1 174±17 133±18 104±21 98±22 
Day 2* 178±14 156±16 134±18 130±18 
* p<0.05 versus day 1 
1116-117 Heart Rate Variabi l i ty Af ter  Exercise Is Related to 
Recovery  of  Parasympathet ic  Tone 
Francis K. Le, Prince J. Kannakedl, Alan H. Kadish, Jeffrey J. Goldberger, Northwestern 
Universi~ Chicago, Illinois. 
To assess the recovery of heart rate variability (HRV) after exercise (Ex) and its relation- 
ship to recovery of parasympathetic (P) effect (PE), 10 normal subjects (5 men, age 33±5 
yrs) exercised on a bicycle ergometer. On day 1, subjects exercised for 14.2±2.3 min- 
utes, to a peak workload of 140±29 Watts and peak HR of 175±16 bpm. On day 2, sub- 
jects exercised using their same day 1 protocol; atropine (0.04 mg/kg) was infused over 2 
minutes during the maximum Ex stage. Upon termination of Ex on each day, a 5 minute 
ECG recording was made. RR interval tachograms were generated and in each 30 sec- 
ond segment, linear regression analysis was performe d, HRV was defined as the root 
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mean square residual (RMS) from the linear regression analysis; RMS quantities the 
deviation of the RR interval from a pure linear change over the 30 sec period. PE was 
defined as the difference in the 30 sec average RR intervals without (day 1) and with 
(day 2) atropine. Results: RMS dramatically increases after I minute of recovery. P 
blockade attenuates the increase in RMS. Day 2 RMS was less than day 1 RMS for all 
time pedods (p<0.03). There was a correlation between day 1 RMS and PE (R2 = 0.63, 
p< 0.0001) Conclusion: RMS is a new measure of HRV that is related to recovery of PE 
after Ex. RMS may help differentiate whether the recently demonstrated prognostic sig- 
nificance of HR recovery after Ex testing is due to P recovery or sympathetic withdrawal, 
both of which decrease HR. If P recovery is more important, RMS may provide better dsk 
stratification than HR recovery. 
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1116-118 Ef fects  of  Nesir i t ide and Dobutamine on Heart Rate 
Variabi l i ty in Patients With Decompensated Heart 
Failure 
Doren Aronson, Dadene P. Horton, Andrew J. Burger, Rambam Medical Center, Haifa, 
Israel, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 
INTRODUCTION: Congestive heart failure (CHF) is characterized by sympathetic over- 
activity and parasympathetic withdrawal. Clinical trials in patients (pts) with decompen- 
sated CHF have shown that nesiritide (brain natriuretic peptide) is associated with 
beneficial hemodynamic effects and symptomatic improvement. Recent studies suggest 
that nesiritide exerts a favorable effect on autonomic dysfunction in CHF. We compared 
the effect of nesirifide and dobutamine (Dob) on heart rate variability (HRV) in decom- 
pensated CHF. 
METHODS: We studied 185 pts admitted for decompensated CHF requiring intravenous 
vasoactive therapy. Baseline 24-h Holters were obtained prior to initiation of the study 
drugs (nesiritide or Dob) and continued for an additional 24-h after initiation of therapy. 
The study population was divided into 2 groups: highly depressed HRV (SDNN < 50 ms) 
and moderately depressed HRV (SDNN = 50-100 ms). HRV time domain indices were 
compared from baseline and treatment Holter recordings. 
RESULTS: In the Dob group, pts with moderately depressed HRV at baseline (n = 20) 
displayed a reduction in indices of total variability such as SDNN (82 ± 4 to 71 ± 4 ms, p 
= 0.01) and SDANN5 (69 ± 3 to 60 ± 4 ms, p = 0.01). Indices of parasympathetic modu- 
lation, pNN50 (7.2 ± 1.5 to 6,6 ± 1.7 %, p = 0.04) and RMSSD (29 ± 4 to 27 ± 4 ms, p = 
0.05), also decreased. With severely depressed HRV (n = 38), no significant changes 
occurred with Dob in indices of overall HRV or parasympathetic modulation. However, in 
the nesiritide group, pts with severely depressed HRV (n = 75) displayed a significant 
increase in SDNN (35 ± 1 to 40 ± 2 ms, p = 0.002), SDANN5 (30 ± 1 to 34 ± 1 ms, p = 
0.02), and RMSSD (13 ± 1 to 15 ± 3 ms, p = 0.01). No significant changes occurred in 
HRV indices with moderately depressed HRV at baseline (n = 53). 
CONCLUSION: In pts with relatively preserved HRV, Dob reduces overall variability and 
parasympathetic modulation. With severely depressed HRV, the effect of Dob on HRV is 
minor, presumably clue to ~,-adrenergic receptor down-regulation or saturation. In con- 
trast, nesiritide improves indices of overall HRV and parasympathetic modulation in pts 
with severely depressed HRV and has no adverse effect on pts with relatively preserved 
HRV. 
1118-119 Altered Fractal Behavior and Heart Rate Var iabi l i ty  in 
Daily Life in Neurally Mediated Syncope 
Bonpei Takase, Haruhiko Hosaka. Yoshihiro Matsushima, Takashi Akima, Syuuichi 
Katsushika, Toshihiko Nishioka, Fumitaka Ohsuzu, Akira Kurita, National Defense 
Medical College, Tokorczawa, Japan, Serf Defense Forces Central Hospital, Tokyo, 
Japan. 
Background: The fractal dimension is an index to the complexity of cardiovascular con- 
trol system and autonomic function is important in the pathogenesis of neurally mediated 
syncope (NMS), However, it is still not fully understood if the derangement of the auto- 
nomic nervous system exists in NMS in daily life. Methods: Thus, we performed 24-hour 
ECG monitoring (AECG) and measured traditional heart rate variability indices (HRV) 
along with long fractal scaling exponent (b) in 36 pts (NMS, 24±3 y/o) with NMS diag- 
nosed by heed-up tilt testing (HUT, 807 tilt) and 11 age-matched normal controls (NL). 
AECG was performed within 48 hours before HUT procedure. For HRV, SDANN, SD, 
rMSSD, pNN50, low frequency (0.04-0.15Hz, LF) and high frequency (0.15-0.40 Hz, HF) 
were measured. All measurements were analyzed in three different periods such as total 
24-hour, awake (09:00-15:00) and sleep (00:00-06:00) phases. The ratio of each mea- 
surements in awake over sleep phase (A/S ratio) was also calculated, Results: Several 
24-hour HRV showed significantly higher values in NMS than those in NL (SD, 91±32 vs 
65±11 ms; rMSSD, 60±31 vs 38±11 ms; pNN50, 30±17 vs 14±7%; LF, 35±15 vs 26¢5 
ms; HF, 27±11 vs 14±7 ms; p<0.05) while 24-hour b was not different (0.95±0.13 vs 
0.95±0.14). In contrast, although NS ratio of any HRV showed no differences,/US ratio 
of b revealed significantly higher value in NMS than in NL (1,7±0.49 vs 1.2i-0.t5, 
p<0.05). The awake and sleep values of b in NMS were also significantly different from 
those in NL, Conclusion; Overall autonomic activity in daily life is exaggerated in NMS. 
Since in most of the time pts are upright during awake and are supine during sleep 
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phase, the significant differences between awake and sleep values of b, and abnormal A/ 
S ratio of b suggest that deteriorated fractat behavior exits in NMS. These findings may 
be associated with the mechanisms of orthostatic intolerance in NMS. 
1116-120 Right Atrial Size May Be a Primary Determinant of Atrial 
Conduction Time of the Sinus Node Impulse 
Susette K. Therkelsen. Bjoem A. Groenning, Uldk Dixen, Gorm B. Jensen, Department 
of Cardiology, Copenhagen University Hospital Hvidovre, Copenhagen, Denmark, 
Danish Research Center of Magnetic Resonance, Copenhagen University Hospital 
Hvidovre, Denmark. 
Background: Prolonged signal-averaged p-wave duration (SAPD) measured by a sig- 
nal-averaged ECG is thought to represent a delay in the intra-atrial conduction of the 
electrical impulse. Prolonged SAPD is a prognostic manker of development of atrial fibril- 
lation (AF). In addition, atrial dilatation in patients with previous AF has been associated 
with dsk of relapse of AF. However, the relation between duration of atrial conduction of 
the electrical impulse and atrial dimensions is not clear. Our aim was to evaluate the cor- 
relation between atdal dimensions measured by magnetic resonance imaging (MRI) and 
the intra-atdal conduction time measured by SAPD. 
Methods: In 7 subjects with no history of cardiac disease, we measured the total filtered 
SAPD. Atrial dimensions were evaluated by cinematographic braathhold MRI scans. 
Results: Right atrial (RA) diastolic volume index (mean+SD=77:P21ml/m2; r=0.83, 
p=0.02), systolic volume index (49~17ml/m2; r=0.76, p=0.05) and stroke volume index 
(29-Z6.7ml/m2; r=0.77, p=0.04) were positively associated with SAPD (135±10.6ms). Left 
atrial (LA) diastolic (64:t:7.1 ml/m 2) and systolic (39~7.3ml/m 2) volume indices and stroke 
volume index (24+1.0ml/m 2) were completely unrelated to SAPD. The combined RA and 
LA diastolic (141.+.21.6ml/m2; r=O.80, p=0.03) and systolic (87.8+17.0ml/m2; r=0.70, 
p=0.08) volume indices correlated positively with SAPD, 
Conclusion: Our results suggest that RA size may be a primary determinant of atdal 
conduction time measured by SAPD. 
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826 External and Implantable Defibrillators: 
Clinical Studies 
Monday, March 18, 2002, 2:00 p.m.-3:30 p.m. 
Georgia World Congress Center, Room 254W 
2:00 p.m. 
826-1 New Therapeutic Option for Patients With Time- 
Dependent Risk of Sudden Cardiac Arrest: Application 
of Novel Wearable Cardloverter-Defibrillator 
Arthur M. Feldman, Helmut Klein, Patrick Tchou, The WEARIT & BIROAD Investigators, 
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, Otto Von Guericke 
Universi~ Magdeburg, Germany. 
Background: Outpatient populations with temporary risk for sudden cardiac arrest (SCA), 
such as patients awaiting cardiac transplant, post-myocardial infarction patients (p-MI) or 
post-CABG patients (p-CABG), often rely on emergency medical services (EMS) for 
defibdllation therapy. Success rates for EMS resuscitation are poor. A new therapeutic 
option, the completely automatic (no bystander intervention) wearable cardioverter- 
defibdllator (WD), may provide better protection for these populations. 
Methods: A mulficenter t ial studied the use of WD (WCD~ system, LIFECOR Inc., Pitts- 
burgh). WD provides automatic detection and treatment of ventricular techycardia and 
fibrillation (VTNF) using unique non-stick ECG electrodes and self-gelling therapy elec- 
trodes. WEARIT sub-population: patients on the cardiac transplant list or equivalent in 
cardiac status. WEARIT subjects used WD until transplanted, hospitalized for transplant 
or circulatory assist device, or receiving an active ICD. BIROAD sub-population: patients 
not receiving an ICD who were p-MI or p-CABG and had either VTNF within 48 hours, an 
ejection fraction < .30 or Killip class > II after 72 hours, or syncopal VTNF after 48 hours. 
BIROAD used WD for -4 months. The effectiveness objective was >25% resuscitation 
success with 90% confidence, The safety objective was <2.3% false shocks per patient- 
month with 90% confidence (500 patient-months minimum). 
Results: There were 8 VTNF SCA events in 6 patients (4 BIROAD, 2 WEARIT). 6 were 
successfully treated, 2 were unsuccessful with V'rNF detected but treatment prevented 
by incorrect patient assembly of WD (therapy electrode in pocket backward, gel released 
away from body). A redesign occurred to prevent this from reoccurring. 6 false shock epi- 
sodes occurred in 873 patlent-months. The most frequently repoded adverse event (20) 
was temporary skin rash under electrodes. 285 patients were enrolled over 3 years. Daily 
